Influence of weeks of circadian misalignment on leptin levels.

"We would like to thank Charles A Czeisler, PhD, MD, and the GCRC dieticians and technicians for study support. This study was funded by NIH HL073196, by NASA Cooperative Agreement NCC9-58 with the National Space Biomedical Research Institute and NASA, and by General Clinical Research Center Grants GCRC M01-RR02635 and M01-RR000051 from the National Center for Research Resources. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data and preparation, review, or approval of the manuscript. Dr Wright received consulting fees, speaker’s fees, clinical trial research contracts and investigator-initiated research grants from Cephalon, Inc. Additionally he has received consulting fees, speakers fees, investigator-initiated research grants and education grants from Takeda Pharmaceuticals North America. Dr Wright has also received consulting fees from Novartis; serving on the advisory board for Zeo Inc. (formerly Axon Labs, Inc) and receiving Nonqualified Stock Options."

"We would like to thank Charles A Czeisler, PhD, MD, and the GCRC dieticians and technicians for study support. This study was funded by NIH HL073196, by NASA Cooperative Agreement NCC9-58 with the National Space Biomedical Research Institute and NASA, and by General Clinical Research Center Grants GCRC M01-RR02635 and M01-RR000051 from the National Center for Research Resources. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data and preparation, review, or approval of the manuscript. Dr Wright received consulting fees, speaker’s fees, clinical trial research contracts and investigator-initiated research grants from Cephalon, Inc. Additionally he has received consulting fees, speakers fees, investigator-initiated research grants and education grants from Takeda Pharmaceuticals North America. Dr Wright has also received consulting fees from Novartis; serving on the advisory board for Zeo Inc. (formerly Axon Labs, Inc) and receiving Nonqualified Stock Options."